Podcasts about placebos

Ce 1er juillet, Alexis plonge les auditeurs de Pop-Rock Station dans une sélection éclectique. On débute avec Suede et leur titre "Disintegrate", annonçant un dixième album pour septembre. Côté nouveautés, Dinosaur Pile-Up présente "Big Dogs", tandis que Francis Zégut choisit "Broken Rib" de Jehnny Beth, extrait de son futur album prévu pour fin août. L'album de la semaine est "Tracks II: The Lost Albums" de Bruce Springsteen, dont on écoute "Repo Man". Shirley Manson et Garbage sont de retour avec "Stupid Girl", et Placebo signe un détour par 2006 avec "Post Blue". Le live de la soirée est assuré par Woodkid depuis Montreux. Paul Banks d'Interpol livre une reprise saisissante de "Sister Midnight" d'Iggy Pop. En fin d'émission, la voix de Prince résonne avec "Erotic City", avant un long format majestueux : "Funeral for a Friend / Love Lies Bleeding" d'Elton John. Suede - Disintegrate Nothing But Thieves - Forever And Ever More Blondie - Atomic Led Zeppelin - Black Dog Dinosaur Pile Up - Big Dogs Muse - Psycho AC/DC - Hells Bells Bruce Springsteen - Repo Man The Seeds - Can't Seem To Make You Mine Jehnny Beth - Broken Rib The Smiths - Hand In Glove Biffy Clyro - A Little Love Fall Out Boy Feat John Mayer - Beat It Garbage - Stupid Girl Placebo - Post Blue Ghost - Satanized Nena - 99 Luftballons Woodkid - Run Boy Run (Live In Montreux) Iron Maiden - The Number Of The Beast Architects - Tear Gas Paul Banks - Sister Midnight Norman Greenbaum - Spirit In The Sky Prince - Erotic City April March - Chick Habit Elton John - Funeral For A Friend Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Are Torn Achilles Injuries on the Rise?The three Long Island scumbags are back, diving deep into the surge of Achilles injuries — and what's behind them. From youth sports burnout to supplement rabbit holes, they cover it all in classic Home Team style:Episode Breakdown:0:00 The three Long Island scumbags return to talk Achilles injuries3:41 Why are so many non-contact Achilles tears happening?6:30 The brutal recovery journey and the mental roadblocks10:00 Theories on what's really causing this spike13:15 Are kids burning through their mileage way too early?15:45 Is CrossFit actually dangerous — or are people just too impatient?19:50 Dennis' Achilles conspiracy: nutrient depletion?!23:10 What supplements should you be taking?27:30 Experimenting with BPC-15731:30 Sleep quality and its overlooked role in recovery33:48 Placebo effects — real or not?39:50 Nutrient symmetry, organ meat blends, and mashed cauliflower45:35 Liver King's meltdown: arrest and a restraining order50:36 Dennis updates us on his BPC-157 use (spoiler: back pain sucks)56:29 Could super shoes be part of the problem?57:30 The 4:06 mile — when the stakes get higher, so does the risk1:02:24 MDV wants a second shot at the bar hang1:04:00 Jason surprises everyone with an L-sit winCatch the full conversation for laughs, honest takes, and a look at how to protect your Achilles (and your sanity). Listen on Apple Podcasts, Spotify, or YouTube — new episodes every Monday, Wednesday, and Friday.

UCSF's Dr. Rahul Aggarwal explains the role of clinical trials in advancing prostate cancer treatment and how trial design is evolving to match today's more personalized approaches. He highlights how UCSF has contributed to major prostate cancer therapies and emphasizes the importance of genetic and genomic testing in identifying suitable trials for each patient. Dr. Aggarwal explains the different trial phases, clarifies common myths—such as concerns about placebos—and stresses that trials are considered at every stage of disease. He also discusses efforts to improve access, affordability, and diversity in trial participation, including regional partnerships and digital matching tools. The talk encourages patients to be informed and proactive when considering clinical trials as part of their treatment plan. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40800]

UCSF's Dr. Rahul Aggarwal explains the role of clinical trials in advancing prostate cancer treatment and how trial design is evolving to match today's more personalized approaches. He highlights how UCSF has contributed to major prostate cancer therapies and emphasizes the importance of genetic and genomic testing in identifying suitable trials for each patient. Dr. Aggarwal explains the different trial phases, clarifies common myths—such as concerns about placebos—and stresses that trials are considered at every stage of disease. He also discusses efforts to improve access, affordability, and diversity in trial participation, including regional partnerships and digital matching tools. The talk encourages patients to be informed and proactive when considering clinical trials as part of their treatment plan. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40800]

UCSF's Dr. Rahul Aggarwal explains the role of clinical trials in advancing prostate cancer treatment and how trial design is evolving to match today's more personalized approaches. He highlights how UCSF has contributed to major prostate cancer therapies and emphasizes the importance of genetic and genomic testing in identifying suitable trials for each patient. Dr. Aggarwal explains the different trial phases, clarifies common myths—such as concerns about placebos—and stresses that trials are considered at every stage of disease. He also discusses efforts to improve access, affordability, and diversity in trial participation, including regional partnerships and digital matching tools. The talk encourages patients to be informed and proactive when considering clinical trials as part of their treatment plan. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40800]

UCSF's Dr. Rahul Aggarwal explains the role of clinical trials in advancing prostate cancer treatment and how trial design is evolving to match today's more personalized approaches. He highlights how UCSF has contributed to major prostate cancer therapies and emphasizes the importance of genetic and genomic testing in identifying suitable trials for each patient. Dr. Aggarwal explains the different trial phases, clarifies common myths—such as concerns about placebos—and stresses that trials are considered at every stage of disease. He also discusses efforts to improve access, affordability, and diversity in trial participation, including regional partnerships and digital matching tools. The talk encourages patients to be informed and proactive when considering clinical trials as part of their treatment plan. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40800]

UCSF's Dr. Rahul Aggarwal explains the role of clinical trials in advancing prostate cancer treatment and how trial design is evolving to match today's more personalized approaches. He highlights how UCSF has contributed to major prostate cancer therapies and emphasizes the importance of genetic and genomic testing in identifying suitable trials for each patient. Dr. Aggarwal explains the different trial phases, clarifies common myths—such as concerns about placebos—and stresses that trials are considered at every stage of disease. He also discusses efforts to improve access, affordability, and diversity in trial participation, including regional partnerships and digital matching tools. The talk encourages patients to be informed and proactive when considering clinical trials as part of their treatment plan. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40800]

Brendan Vermeire, FMHP opens with a powerful assessment: Americans are sicker than ever, weighed down by lifestyle-related illness, toxic overload, and chronic stress. He stresses mindset—victim vs. victor mentality—as the pivotal factor in healing, followed closely by consistent exercise. We then explore the hidden burden of environmental toxins (glyphosate, EMFs, mold, VOCs, microplastics, PFAS) that erode hormonal balance, metabolism, and immunity. Brendan argues that while pharmaceuticals like Ozempic have a role, they must be used within the context of proper nutrition, movement, and psychological resilience. Finally, he pitches his new “Mastering Mold Illness” course and textbook—designed to train practitioners and help more people reclaim their lives.00:00 – 01:00 | Brendan agrees: “The American collective has never been more compromised.”01:00 – 03:00 | Lifestyle-induced illness: 88% metabolically ill, 70% overweight—“It's staggering.”03:11 – 05:00 | Mindset matters: “Victim or Victor, it's your choice.”05:15 – 06:30 | Power of resilience: “Placebo‑nocebo... do I believe I can heal?”09:36 – 10:07 | Exercise wins: “What type of movement do you enjoy?”14:19 – 16:31 | Toxic environment: “We ingest, breathe, drink… this toxic soup.”20:05 – 21:03 | Hormones + peptides: “Can move the needle fastest with quality of life.”32:34 – 35:02 | Blood chemistry: “People who apply themselves in the gym get better results.”36:14 – 38:36 | Ozempic nuance: “Minimum effective dose is always a good way to go.”40:06 – 41:35 | Course launch: “Mastering Mold Illness” and accompanying textbook.

Was hat es mit Ceddos mysteriösem Zaubertrank auf sich – und können Supplements wirklich was verändern?

Efficacy And Safety of AZD0780, An Oral Small Molecule PCSK9 Inhibitor For Treatment Of Hypercholesterolemia: Results From A Ph2b Randomized Placebo-controlled Clinical Trial

For the seventy-sixth episode of the It's Just A Hill Cycling Podcast, Jon is joined by friend of the club and returning guest Brian Cauti. Brian's been on a bit of a journey lately—recovering from a long-term injury, training with the Rhode Island Track Club (yes, running), and opening a pizza shop. In this episode, they talkContinue reading "Placebos, Pain & Pizza with Brian Cauti | IJAH Pod 076"

The Effect of Once-weekly Subcutaneous Semaglutide on Functional Capacity in People with Type 2 Diabetes and Peripheral Artery Disease: Primary Results from the Phase 3b, Randomized, Placebo...

Placebo - The Bitter End Pat Benatar - Love Is The Battlefield Yungblud - Tissues Linkin Park - One Step Closer The Warning - Hell You Call A Dream Red Hot Chili Peppers - Give It Away Coldplay -Feelslikeimfallinginlove Lykke Li - I Follow Rivers (The Magician remix) Two Door Cinema Club - Something Good Can Work The Human League - Don't You Want Me (Purple Disco Machine remix) Daft Punk Feat. Pharrell Williams & Nile Rodgers - Get Lucky (Kenwork 10th Anniversary Mix) Fleetwood Mac - Dreams Muse - Undisclosed Desires Madonna - Express Yourself Cher - The Shoop Shoop Song (It's In His Kiss) Prince - Girls & Boys Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Ce 12 juin, Marjorie Hache vous prépare une soirée Pop-Rock Station bien rythmée avec Placebo, The Stooges, Tina Turner, et Dire Straits. Côté nouveautés, on découvre le nouveau titre de Wet Leg, "CPR", Sleep Token, Machine Head, CMAT, Elephant et Panic Shack. L'album de la semaine reste "More" de Pulp, avec ce soir le titre "Tina", une chanson post-divorce signée Jarvis Cocker. La reprise du jour est le percutant "Killing In The Name Of" de Rage Against The Machine, revisité avec délicatesse par La Maison Tellier. Le live du jour est signé Otis Redding avec "Shake", capté en 1965 lors de sa tournée européenne. Wet Leg - CPR Placebo - Pure Morning Robyn - Call Your Girlfriend Editors - Papillon Sleep Token - Damocles The Stooges - 1969 Wolfmother - New Moon Rising Pulp - Tina Tina Turner - Goldeneye Elephant - For A Friend The Velvet Underground - I'm Waiting For The Man CMAT - Take A Sexy Picture Of Me La Maison Tellier - Killing In The Name The Cardigans - Erase And Rewind Machine Head - Bønescraper Dire Straits - Down To The Waterline My Chemical Romance - I'm Not Okay (I Promise) Otis Redding - Shake (Live In Europe) Pearl Jam - Dark Matter Ram Jam - Black Betty Panic Shack - Girl Band Starter Pack Dead Kennedys - Viva Las Vegas Kasabian - Shoot The Runner The Coral - Pass It On The Prodigy - Breathe Black Sabbath- Warning Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Shallow and Jiunta unpack a wild placebo study where elite powerlifters and sprinters were told they were on steroids... but weren't.  We dive into the psychology of belief, placebo effects, and how the mind might be the most underutilized performance-enhancer in training.  It's time we get serious about exercise prescription. Join the PSL1 waitlist now! https://www.pre-script.com/psl1 FREE Coach's Field Guide: https://www.pre-script.com/coachs-field-guide We've got a new sponsor! Marek Health is a health optimization company that offers advanced blood testing, health coaching, and expert medical oversight. Our services can help you enhance your lifestyle, nutrition, and supplementation to medical treatment and care. https://marekhealth.com/rxd Code RXD Don't miss the release of our newest educational community - The Pre-Script ® Collective! Join the community today at www.pre-script.com. For other strength training, health, and injury prevention resources, check out our website, YouTube channel, and Instagram. For more episodes, subscribe and tune in to our podcast. Also, make sure to sign up to our mailing list at www.pre-script.com to get the first updates on new programming releases. You can also follow Dr. Jordan Shallow and Dr. Jordan Jiunta on Instagram! Dr. Jordan Shallow: https://www.instagram.com/the_muscle_doc/ Dr. Jordan Jiunta: https://www.instagram.com/redwiteandjordan/ Croissants and Intravenous Drugs (00:00:00) Drug vs. Alcohol Logic: The Dark Humor Segment (00:02:00) Performance vs. Feeling Good (00:09:40) The Steroid Placebo Study Breakdown (00:10:18) The Psychology Behind Perceived Strength (00:14:10) Belief vs. Recovery: What's Really Helping? (00:15:26) The Power of Perception in Training (00:16:12) Coaching as a Placebo? (00:20:28) What Athletes Actually Trust (00:24:06) Outliers and Self-Belief (00:27:14) When Placebos Wear Off (00:29:16) Kobe, Floyd, and the Power of Belief (00:31:00) Mental Weakness or Missed Opportunity? (00:36:00) Confidence, Self-Doubt, and Growth (00:39:00) Steroids, Fairness, and the Playing Field (00:41:00)

N Engl J Med 2001;345:1667-1675Background: Angiotensin II is a peptide hormone that is part of the renin–angiotensin–aldosterone system (RAAS). Angiotensin II is a potent vasoconstrictor and growth-stimulating hormone. Data suggested that it plays a role in ventricular remodeling and progression of heart failure. Although treatment with angiotensin-converting enzyme inhibitors (ACEi) reduce angiotensin II levels, physiologically active levels of angiotensin II may persist despite long-term therapy.Cardiology Trial's Substack is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber.The Valsartan Heart Failure Trial (Val-HeFT) sough to assess whether the angiotensin-receptor blocker valsartan, could reduce mortality and morbidity when added to optimal medical therapy in patients with systolic heart failure.Patients: Eligible patients had left ventricular ejection fraction less than 40% and left ventricular dilation, in addition to having clinical heart failure for at least 3 months with NYHA class II, III or IV symptoms. Patient also had to have been receiving a fixed-dose drug regimen for at least two weeks, that could include ACEi, diuretics, digoxin, and beta-blockers.There were many exclusion criteria. We mention some here: Postpartum cardiomyopathy, acute myocardial infarction within 3 months, coronary artery disease likely to require intervention, serum creatinine >2.5 mg/dL and life expectancy less than 5 years.Baseline characteristics: Patients were recruited from 302 centers in 16 countries. The trial randomized 5,010 patients – 2,511 randomized to receive valsartan and 2,499 to receive placebo.The average age of patients was 63 years and 80% were men. The average left ventricular ejection fraction was 27%. Cardiomyopathy was ischemic in 57% of the patients. The NYHA class was II in 62% of the patients, III in 36% of the patients and IV in 2%.Approximately 26% had diabetes and 12% had atrial fibrillation.At the time of enrollment, 86% were taking a diuretic, 67% were taking digoxin, 35% were taking beta-blockers, and 93% were taking ACEi.Procedures: The trial was double-blinded. The trial had an initial run-in period for 2 - 4 weeks where patients received placebo twice daily. This was performed to confirm patients' eligibility, clinical stability and compliance.Patients were assigned in a 1:1 ratio to receive valsartan or placebo. Randomization was stratified according to whether or not they were receiving a beta-blocker.Valsartan was started at a dose of 40 mg twice a day, and the dose was doubled every two weeks to the target dose of 160 mg twice a day. Placebo doses were adjusted in a similar way.Follow up occurred at 2, 4, and 6 months and every 3 months thereafter.Endpoints: The trial had two primary end points. The first was all-cause mortality. The second was the combined end point of mortality and morbidity, which was defined as cardiac arrest with resuscitation, hospitalization for heart failure, or administration of intravenous inotropic or vasodilator drugs for four hours or more without hospitalization.The estimated sample size was 5,000 patients. The sample size calculation assumed 20% relative risk reduction in mortality with valsartan assuming 906 patients would die during the trial. This sample size would provide the trial 90% power at 0.02 alpha. Alpha was 0.02 instead of the traditional 0.05 since the trial had two primary endpoints and to adjust for the interim analyses.Results: The target valsartan dose of 160 mg twice a day was achieved in 84% of the patients. The reduction in systolic blood pressure was greater with valsartan vs placebo – mean of 5.2 ± 15.8 mm with valsartan compared to 1.2 ± 14.8 mm Hg with placebo, at 4 months.All-cause mortality was not different between both groups (19.7% with valsartan vs 19.4% with placebo, RR: 1.02, 95% CI: 0.88 – 1.18; p= 0.80). The second co-primary endpoint was reduced with valsartan (28.8% vs 32.1%, RR: 0.87, 95% CI: 0.77 – 0.97; p= 0.009). This was driven by reduction in hospitalizations for heart failure (13.8% vs 18.2%). Cardiac arrest with resuscitation was 0.6% with valsartan and 1.0% with placebo. All-cause hospitalization was numerically lower with valsartan, however, this was not statistically significance (2,856 vs 3,106; p= 0.14). The mean change in ejection fraction was higher with valsartan (4.0% vs 3.2%; p= 0.001). More patients had improvement in NYHA classification with valsartan (23.1% vs 20.7%; p

What we water grows. Energy Follows thought. Our eyes and our feet are connected! We move in the direction of our FOCUS, and we FOCUS on the direction of our movement! We are unconscious creatures. So much of what we do is happening below the surface of our conscious thought and effort. However, the effects are just as real, powerful and lasting as those things we do that we are consciously aware of. Today On Like It Matters Radio Mr. Black wants listeners to get the power of our BELIEF SYSTEMS. Everything we do, or DO NOT do, is driven by a belief. Beliefs come from what we think about, and how we frameprocess the experiences from our past. Again, many of these BELIEFS and THOUGHTS are happening at the unconscious level- yet having catastrophic outcomes- UP UNTIL NOW. Today Mr. Black will share with listeners the knowledge that leads to application. Topics of discussion for this hour of power are Placebo, Nocebo, Epigenetics, Carolyn Leaf, Bruce Lipton- Biology of Belief. Listeners will also hear a few great stories and some poetry. Tune in and be inspired to live LIFE LIKE IT MATTERS- it is the Way of Warrior! Be sure to Like and Follow us on our facebook page!www.facebook.com/limradio Instagram @likeitmattersradioTwitter @likeitmatters Get daily inspiration from our blog www.wayofwarrior.blog Learn about our non profit work at www.givelikeitmatters.com Check out our training website www.LikeItMatters.Net Always available online at www.likeitmattersradio.comSee omnystudio.com/listener for privacy information.

Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease Compared to Placebo: The Ekstrom Trial

Dr Chris answers listener questions including, how effective is the flu shot? Is there anything doctors don't want their patients to know? Do our eyes stay the same size through our lives? Could working in a dusty cement environment lead to health problems? When someone has dementia, how long will they live? Will doctors prescribe remedies purely to induce a placebo effect? Like this podcast? Please help us by supporting the Naked Scientists

Dr Chris answers listener questions including, how effective is the flu shot? Is there anything doctors don't want their patients to know? Do our eyes stay the same size through our lives? Could working in a dusty cement environment lead to health problems? When someone has dementia, how long will they live? Will doctors prescribe remedies purely to induce a placebo effect? Like this podcast? Please help us by supporting the Naked Scientists

Un grand merci à LAROQ de sponsoriser une nouvelle fois notre épisode. Ils créent du matériel de haute qualité, et tout est fait en France, dans mon Sud ensoleillé ! Si tu cherches à t'équiper contacte les direct via leur site : https://www.laroq.com/ et avec le code SECRET tu auras des réductions supplémentaires ! ___________ Fred Caussé est un kinésithérapeute et préparateur physique qui est passionné du mouvement et de la performance sous toutes ses formes. En plus d'avoir son cabinet, il accompagne des sportifs jusqu'au plus haut niveau olympique. Fervent pratiquant de sports de force, il a testé sur lui même de nombreux protocoles. Et cet épisode c'est ça, un melting pot d'expériences, de méthodes et de techniques pour être prêt à performer à tout moment. Sans blessure, sans peur. On aborde ensemble : - La notion d'échauffement - Le neurotraining - La préparation olympique de Frank Ntilikina - L'effet Placebo à l'entrainement et en rééducation - Gestion de la blessure ____________ A dans 15 jours pour le prochain épisode, en attendant on se retrouve dans le Club des Entraineurs Juste en cliquant ici : https://le-club-des-entraineurs.webflow.io/ ____________ Retrouve nous également sur les réseaux sociaux Instagram : https://www.instagram.com/secretsdentraineurs/ LinkedIn : https://www.linkedin.com/in/julien-vecchione-714147155/ Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

In 10 Tagen zur gesündesten Version deiner selbst: bist du dabei?  Diese Podcast Episode wird besonders spannend, denn heute verrate ich Dir, wie du dich in genau 10 Tagen deutlich besser und fitter fühlen wirst.  Glaubst du nicht? ist aber so! Und die wichtigste Nachricht gibt es sogar direkt vorab: unser Körper ist ein Regulierungsmeister. Unser Körper ist in der Lage uns selbst zu heilen. Aber was genau bedeutet das; dass unser Körper sich selbst heilen kann?wie wirken diese Selbstheilungskräftewas hat es mit Placebo auf sich?Wir müssen endlich von dem weg kommen, dass uns nicht gut tut; und es gegen Lebensmittel tauschen, die sehr gut für uns sind. Aber es sind nicht nur die falschen Lebensmittel, die uns krank machen. Da ist noch der ganze Stress, dem wir täglich ausgesetzt sind. Viele Menschen haben Schlaf Probleme, egal ob ein oder durchschlafen oder fehlende Tief oder REM Phasen und nicht zu vergessen, die ganzen Umweltgifte.Viele Menschen haben diese Dinge nicht auf dem Schirm und machen sich darüber auch keine Gedanken, wenn es ihnen schlecht geht. Und viele Ärzte sind ratlos, wenn wir in die Praxis gehen und sagen, dass es uns nicht gut geht.   Aber wie kann das sein? und was hat unser Gehirn mit unserem Darm zu tun? Warum heisst es, dass der Darm das zweite Gehirn ist? Und was für eine Erkrankung verbirgt sich hinter dem Begriff Leaky Gut?  Was hat unser Gehirn mit stillen Entzündungen, Herzerkrankungen, Demenz, Autoimmunerkrankungen und Diabetes zu tun?  Was haben Fast Food, Alkohol und Zucker mit dem Wandel zu tun und wie und warum schaffst du es auf jeden Fall, dass du dich in exakt 10 Tagen um so viel besser fühlen wirst?   All das verrate ich in dieser Podcast Episode .  Deine MIMI LAWRENCE Werbepartner: Ahead: Code Mimi HIER GEHTS LANGMein Buch: WENN NICHT JETZT, WANN DANN?! erscheint im Mai 2025: Hier lang zu Thalia Hier zu Amazon Instagram @mimilawrencefitness INSTAGRAM NEUER KANAL: @mimilawrencegesundheit Youtube: MIMI LAWRENCE FitnessWebseite: mimilawrence.comTik Tok @mimilawrencefitness

It's Bravo chaos — one day early!

Dr. Caleb Burgess is a Doctor of Physical Therapy and Certified Strength and Conditioning Coach who joins me to discuss:-How being an overall healthier person means you typically have less pain and recover from injury better-How repetitive movements and sustained postures may lead to injury risk-Why slouched positions aren't inherently risky for injury, but lack of variety of movement may be -If exercise technique has any relationship with pain-If it's ok to play up the placebo effect of some treatments if someone feels better-And much more00:57 The Overestimation of Specific Treatments01:32 Holistic Health and Pain Management03:24 The Role of Lifestyle in Recovery03:50 Belief and Placebo in Therapy09:09 Challenges in Patient Beliefs and Expectations12:57 The Power of Placebo and Ethical Considerations19:39 The Importance of Movement and Posture27:08 Understanding the Construction Worker's Physical Demands28:31 The Importance of Load Management29:58 The Cup Analogy for Capacity Building31:24 Personal Anecdotes on Physical Training33:06 Does Exercise Technique Matter?43:11 Factors Influencing Pain Beyond Physical Activity47:54 Conclusion and ResourcesI've been putting a lot of time and effort into making these new episodes valuable for you. You can help me get these great guests and their knowledge in front of more people by:-Subscribing and checking out more episodes-Sharing on your social media (please tag me - I promise I'll respond)-Sharing with the friend you think of who needs this episodeFollow Andrew Coates:Instagram:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andrewcoatesfitness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join My Email List:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.andrewcoatesfitness.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Get the RP App at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.rpstrength.com/coates⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - use the code COATESRPUse Code ANDREWCOATESFITNESS to save 10% off at ⁠⁠⁠⁠⁠⁠⁠https://justbitememeals.com/⁠⁠⁠⁠⁠⁠⁠Use Code ANDREW for extended free trial of MacrosFirst Premium ⁠⁠⁠⁠⁠⁠⁠https://www.macrosfirst.com/

Bienvenido a otra de estas sesiones semanales de gordeo auditivo, noticias y discusiones acaloradas. En esta ocasión contamos con la presencia de parte del staff de 3gb.com.mx: Eze y Rafa además de nuestro invitado Rodrigo Martínez "El Vikingo" (@Rodo_el_Vikingo) En este medio episodio nos vamos a "El Sillón" para hablar sobre MARVEL 1943: Rise of Hydra se retrasa Jade Raymond sale de Haven Studio Fecha para Stellar Blade en PC Persona 5: The Phantom X llega a nuestro continente. Y harto más... En el "Tema de la Semana" hablamos sobre el confuso estado actual del formato físico en los videojuegos.

Dietitians, Leah Heigl & Aidan Muir, explore the effects of alcohol on muscle growth and recovery. They discuss the overall mechanisms that may impact it, and what the overall impact is according to the research.    (0:00) - Introduction (0:34) - Mechanisms (1:43) - Study 1: MPS Difference from Protein vs Protein + 12 Standard Drinks (3:55) - Study 2: Recovery Differences from Placebo vs 10 Standard Drinks (5:58) - Study 3: Systematic Review: Impact on MPS from Alcohol (7:04) - Our Thoughts & Practical Takeaway     WEBSITE:  https://www.idealnutrition.com.au/ PODCAST:  https://www.idealnutrition.com.au/podcast/ INSTAGRAM:  https://www.instagram.com/idealnutrition__/?hl=en   Our dietitians

Wet Leg ouvre ce RTL2 Pop-Rock Station avec "Catch These Fists", premier extrait de leur nouvel album "Moisturizer". Marjorie Hache rend ensuite hommage à BB King, le légendaire bluesman disparu il y a dix ans, avec "The Thrill Is Gone". Les sonorités rock psyché africaines de Witch font également leur retour avec "Queenless King". Un classique avec Dolly Parton et "Jolene", avant de plonger dans l'album de la semaine signé Sleep Token avec "Damocles", porté par la voix intense de Vessel. Francis Zégut recommande Destroyer avec "Cataract Time", tandis que Pulp nous propose "Spike Island", extrait de leur nouvel album "More". La reprise de la soirée nous propose un classique de David Bowie, "Heroes", magnifié en concert par Blondie. The White Stripes frappent avec "Blue Orchid", suivi de Dinosaur Pile Up et leur nouveauté "My Way". Les Queens Of The Stone Age nous offrent un live énergique de "No One Knows", enregistré à Glastonbury. Natalie Bergman dévoile "Gunslinger", extrait de son prochain album "My Home Is Not In This World". La soirée s'achève en beauté avec Vampire Weekend, Laura Marling, Placebo et enfin les Deftones avec "Pink Maggit". Wet Leg - Catch These Fists (Radio Mix) Depeche Mode - A Pain That I'm Used To Bb King - The Thrill Is Gone Neil Young & The Crazy Horse - Break The Chain Witch - Queenless King Dolly Parton - Jolene Sleep Token - Damocles The Smiths - Girlfriend In A Coma Destroyer - Cataract Time The Turtles - Happy Together Pulp - Spike Island Blondie - Heroes (Live) The White Stripes - Blue Orchid Oasis - Cigarettes & Alcohol Dinosaur Pile Up - My Way The Who - Pinball Wizard Courtney Barnett - Pedestrian At Best Queens Of The Stone Age - No One Knows (Live Glastonbury 2023) Rose Tattoo - Rock N Roll Outlaw Papa Roach - Last Resort Natalie Bergman - Gunslinger Jimi Hendrix - Foxy Lady Vampire Weekend - A-Punk Laura Marling - Alexandra Placebo - Battle For The Sun Deftones - Pink Maggit Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

(no music) (10 hours) Placebo, Belief and Expectation | Let me bore your pain away #32 | Jason Newland | 5th May 2025 by Jason Newland

(music) (5 hours) Placebo, Belief and Expectation | Let me bore your pain away #32 | Jason Newland | 5th May 2025 by Jason Newland

(no music) Placebo, Belief and Expectation | Let me bore your pain away #32 | Jason Newland | 5th May 2025 by Jason Newland

(no music) (5 hours) Placebo, Belief and Expectation | Let me bore your pain away #32 | Jason Newland | 5th May 2025 by Jason Newland

(music) (10 hours) Placebo, Belief and Expectation | Let me bore your pain away #32 | Jason Newland | 5th May 2025 by Jason Newland

(music) Placebo, Belief and Expectation | Let me bore your pain away #32 | Jason Newland | 5th May 2025 by Jason Newland

Darin: Planet 10, Mondstation, Placebos, Nostalgie, Neue Farbe “olo”: 00FFCC, Freundschaft & Geruch, Hungrig einkaufen, ITER (Tokamak/Stellarator), PANGEA, Hören Lesenswert: Rushkoff Survival of the Richest*, Hörenswert: Sternengeschichten (Hörbuch) Florian (und andere) live sehen: Sternengeschichten, Sciencebusters Hier Florian direkt unterstützen! *Affiliate-Link: Wer über diesen Link Amazon betritt, lässt mir bei allen Käufen der Session eine Provision […]

Does having an injury or pain mean you need to stop moving? In this episode of The Body Nerd Show, I'm joined by Dana Jones, host of The Pain Free Athlete Podcast, for a myth-busting conversation about pain, injury, and movement. Together, we debunk some of the most common and harmful fitness myths that keep you stuck. If you've ever wondered what to do when you're in pain, why rest isn't always the best solution, or how to stay active safely, this episode is for you. Dana and I also dive into the mindset shifts that help you navigate workouts and life — even when you're in pain. You'll learn: Why no pain, no gain is not true (especially if you're already in pain Why pain doesn't have to be a normal part of aging How to navigate your workouts when you're injured or in pain All the links: Pain Free Athlete Podcast @painfreeathletepodcast on Instagram Dana's journaling prompts for pain Boulder Back Pain Study - Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial Nicole Sachs - Break Awake 30 days to more strength + flexibility with the Mobility Mastery Toolkit www.aewellness.com/podcast - Show notes, links and more. Come hang out with me on Instagram @hollaformala : https://instagram.com/hollaformala/ TikTok @ aewellness Bodywork Starter Guide - learn the 6 places you need to roll right now for quick relief, plus the reason why what you've tried so far has only given you a temporary fix. Download the guide for free now at www.aewellness.com/bodywork 818-396-6501 is the Body Nerd Hotline - how do you build consistency and/or where are you getting stuck? Drop me a line and let me know your body nerd hacks - you might just hear your voice on a future episode!   Today's episode of The Body Nerd Show is brought to you by Movement Mavens™ Therapy Balls—the official mobility tool of the show and the best way to keep your body moving pain-free. Tight hips? Stiff back? Movement Mavens Therapy Balls are designed to mimic the feel of a massage therapist's hands, helping you release tension, improve flexibility, and move better—every single day. Because let's be real—foam rollers are meh, and tennis balls? Not even close. Get the best. Your body deserves it. And right now, you can save 25% on all therapy balls, kits, and workshops with code BODYNERD25. Shop now at www.aewellness.com/shop-now/  

TODAY ON THE ROBERT SCOTT BELL SHOW: Prasad In, Marks Out, NIH Shuts Beagle Lab, Placebo Trial Backlash, Hydroxychloroquine Study Retracted, Copaiva Officinalis, Karma Bias, Drug-Induced Nutritional Deficiencies, Florida Bans Fluoride, RFK Jr. Autism Critics, Food Beats Painkillers, and MORE! https://robertscottbell.com/prasad-in-marks-out-nih-shuts-beagle-lab-placebo-trial-backlash-hydroxychloroquine-study-retracted-copaiva-officinalis-karma-bias-drug-induced-nutritional-deficiencies-florida-bans-fluoride-r/ Please read this disclaimer carefully before you (“you”, “your”) use our [Your Website URL] website (“website”, “service”) operated by the [Your Business Name] (“operator”, “us”, “we”, “our”). Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing t

(music) (10 hours) Placebo, Belief and Expectation | Let me bore your pain away #32 | Jason Newland | 5th May 2025 by Jason Newland

(music) (5 hours) Placebo, Belief and Expectation | Let me bore your pain away #32 | Jason Newland | 5th May 2025 by Jason Newland

Last week, Health Secretary Robert F. Kennedy Jr. announced that the Food and Drug Administration would require all new vaccines to be tested against placebos and to develop new vaccines without using mRNA technology. Christina Jewett, reporter covering Food and Drug Administration for The New York Times, explains what that will mean for future vaccines, including COVID-19 booster shots, plus more FDA-related news headlines.

The multi-faceted aesthete & artiste known as Justin Warfield (She Wants Revenge, Warfield, One Ince Punch, guest vocals on tracks from Placebo, Bomb The Bass and several appearances on Saved By The Bell) joins me for what was going to be all about the cult classic SURF II, but we had a whole lot to say about a whole lotta other things. And that hat includes a LOT of movies, Los Angeles legends and more.Born and raised in Los Angeles, Justin has been plugged into all LA magic since birth. Video stores, bands, films and so much more.As for SURF II? Well, there's no SURF 1, the poster tagline is "The End Of The Trilogy" and this is the movie that gave the world BUZZ Cola. That explains it pretty clearly, no? Out-of-print for decades, you can now see it in HD splendor thanks to the fine folks at Vinegar Syndrome Written & Directed by Randall Badat, Starring Eddie Deezen, Corinne Bohrer, Eric Stoltz, Ron Palillo, Tom Villard, Cleavon Little, Ruth Buzzi, Terry Kiser, Linda Kerridge, Lucinda Dooling and Lyle Waggoner,.Find more of everything Justin at his website Join the Craig & Friends PatreonJustin on Instagram Craig & Friends Linktree - subscibe now on YouTube

Are super shoes a super placebo? A randomised crossover trial in female recreational runners Hébert-Losier K, Pfister A, Finlayson SJ, et al. Footwear Sci. Published Ahead of Print. doi:10.1080/19424280.2025.2458330 Due to copyright laws, unless the article is open source we cannot legally post the PDF on the website for the world to download at will. Brought to you by our sponsors at: CSMi – https://www.humacnorm.com/ptinquest Learn more about/Buy Erik/Jason/Chris's courses – The Science PT Support us on the Patreons! Music for PT Inquest: “The Science of Selling Yourself Short” by Less Than Jake Used by Permission Other Music by Kevin MacLeod – incompetech.com: MidRoll Promo – Mining by Moonlight Koal Challenge – Sam Roux

 Good Morning America, CNN ~This episode is for informational purposes. Please discuss any new info with your doctor before starting any new treatments for your health.Our favorite house Doc is spotlighting  Tips for Overall Health & WellnessJacob is also a frequent expert on CNN, Dr. Oz Show, Martha Stewart Living & Ricki Lake Show. He is author of the free iPhone application "Natural Cures." Having overcome Chronic Fatigue Syndrome (CFS) and Fibromyalgia in 1975 (which left him homeless much of that year), he has helped hundreds of thousands recover from CFS and Fibromyalgia. He is senior author of the landmark studies "Effective Treatment of Chronic Fatigue Syndrome and Fibromyalgia -- a Placebo-controlled Study" and "Effective Treatment of CFS and Fibromyalgia with D-Ribose." Author also of the best-selling book The Fatigue & Fibromyalgia Solution", "Real Cause, Real Cure", "From Fatigued to Fantastic!" (3rd revised edition, Avery/Penguin Group), "Beat Sugar Addiction Now!" (Fair Winds Press) and "Pain Free 1-2-3 - A Proven Program for Eliminating Chronic Pain Now" (McGraw-Hill). His web site www.endfatigue.com has many resources on Natural Healing, including a free online "Symptom Analysis" questionnaire, which can analyze your symptoms (and even lab tests if available) to determine what is causing your fatigue or Fibromyalgia, and what is needed to reclaim your health!© 2025 All Rights Reserved© 2025 BuildingAbundantSuccess!!Join Me on ~ iHeart Media @ https://tinyurl.com/iHeartBASSpot Me on Spotify: https://tinyurl.com/yxuy23baAmazon Music ~ https://tinyurl.com/AmzBASAudacy:  https://tinyurl.com/BASAud

New Underground Beats & Underground Culture Vibes on Green Coast Radio!

Desarrollamos el problema de los aranceles, la verdad sobre las imitaciones de China y lo que too esto puede significar para las personas que se creen superiores por comprar marcas de lujo.

Send us a textAzithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial.Lowe J, Gillespie D, Aboklaish A, Lau TMM, Consoli C, Babu M, Goddard M, Hood K, Klein N, Thomas-Jones E, Turner M, Hubbard M, Marchesi J, Berrington J, Kotecha S.Lancet Respir Med. 2024 Aug;12(8):608-618. doi: 10.1016/S2213-2600(24)00079-1. Epub 2024 Apr 25.PMID: 38679042 Free article. Clinical Trial. As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Iranian-American director and writer Saman Kesh has the most Vimeo staff picks, ever. He attributes this accolade to excessive consumption of rocket fuel and a knack for combining the human experience with a healthy dose of controlled chaos. Saman gained recognition with popular music videos like Cinnamon Chasers: Luv Deluxe (which won ‘Best Video' at SXSW), Kygo: Stole The Show and Basement Jaxx: Never Say Never, along with videos for Calvin Harris, Ed Sheeran, and Placebo. He has also directed award-winning commercials for major brands like Zoom, Google, Uber, Toyota and Nintendo. Saman has written and directed industry-hailed short films, CONTROLLER and HIT TV, and is currently developing several feature films. On his off hours, he plays video games and trolls racists. Topics Discussed In This Episode: Yoshino and Saman catching up (00:02:14) Imbuing authenticity into commercial creations (00:05:54) Saman speaks about his experience shooting the “Azizam” music video for Ed Sheeran (00:20:38) Saman reflects on 15 years in the film and commercial industry (00:29:43) Saman discusses dealing with triggering moments on set, and how he has learned to comport himself appropriately in those situations (00:39:04) Yoshino asks about romantic relationships and finding a shared rhythm with a partner (00:43:44) Knowing how to make the most truthful decisions for our lives (00:49:56) Getting out of analysis paralysis (00:56:24) Saman reflects on how his past self might perceive who he is today (00:59:00) artistdecoded.com samankesh.com instagram.com/saman_kesh  

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Eli Lilly will start a lcinical trial for tirzepatide for people with type 1 diabetes, more details on Dexcom's 15 day G7 sensor, Ozepmic pill form tested, type 5 diabetes identified and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Our top story this week.. Eli Lilly takes the first steps toward getting tirzepatide approved for people with type 1 diabetes. Tirzepatide is sold under the brand names Mounjaro for type 2 and Zepbound for obesity. The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or are overweight. Participation in the study will last about 49 weeks. Official Title A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Tirzepatide Once Weekly Compared to Placebo in Adult Participants With Type 1 Diabetes and Obesity or Overweight This is a big deal because, even though many people with type 1 are able to get a prescription for tirzepatide, it's not approved for T1D and so insurers won't usually cover it.   https://clinicaltrials.gov/study/NCT06914895 XX The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there's little information on the drugs' safety and effectiveness for the condition. The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. But the clinical trials of these medications specifically excluded people with type 1 diabetes, who are dependent on the hormone insulin to survive because they can't make enough of their own. Drugmakers feared that using the GLP-1 medications with insulin might raise the chance of dangerously low blood sugar events, or hypoglycemia, and were unwilling to take the risk of studying them in people with type 1.   For the study, which was published last month in the journal Diabetes, Obesity, and Metabolism, researchers at Johns Hopkins University reviewed the medical records of more than 200,000 people with type 1 diabetes from 2008 to 2023. They grouped the data in three-year periods, starting with October 2008 to September 2011 and ending with October 2020 to September 2023. GLP-1 medication use spiked, as well. Among adults with the highest category of obesity, about 4% used GLP-1 medications in 2008, and 33% did by 2023 – an 800% increase. But these are anecdotal reports and may not reflect instances in which people have side effects or complications like low blood sugar, which can be life-threatening. But Shin says what's really needed is information from randomized, double-blinded studies, in which participants are followed forward in time and given either a drug or a placebo. https://www.cnn.com/2025/04/09/health/glp-1-type-1-diabetes-study/index.html   XX Later this month the FDA will conduct a final meeting regarding a new, investigational compound (sotagliflozin) soda-GLIFF-a-zin that has been shown to Improve QoL and Reduce Long-term Complications for people with type 1 diabetes (T1D). The patient advocacy group Taking Control of Your Diabetes (TCOYD.org) is working to inform the T1D community about sotagliflozin - and to encourage people to sign a Change.org petition directed towards FDA.  Last fall, the FDA declined to approve sotagliflozin due to concerns about a potential increased risk of diabetic ketoacidosis (DKA), despite this being a condition that people with T1D on insulin face and manage daily. While TCOYD respects FDA's caution, the group stands by T1D patients and their physicians who, as a team, balance risks and benefits every day. https://tcoyd.org/petition/ XX Dexcom receives FDA approval for it's G7 with 15 day wear. We have an interview with Chief Operating Officer Jake Leach coming up on Tuesday – we talk about the planned roll out of this sensor, what else has changed, and the fine print in the press release – it says    “A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per package labeling, approximately 26% of sensors may not last for the full 15 days.   https://investors.dexcom.com/news/news-details/2025/Dexcom-G7-15-Day-Receives-FDA-Clearance-the-Longest-Lasting-Wearable-and-Most-Accurate-CGM-System/default.aspx?utm_source=www.diabetech.info&utm_medium=referral&utm_campaign=dexcom-g7-15-day-sensor-gets-fda-cleared-but-will-it-actually-last-that-long   XX Glucotrack is joining something called  FORGETDIABETES bionic pancreas initiative, - this is an European Union project that aims to develop a long-term automated insulin delivery system for type 1 diabetes patients. Glucotrack's Continuous Blood Glucose Monitor (CBGM) will be integrated into the system to provide real-time glucose readings. The initiative's goal is to create a bionic invisible pancreas that eliminates the need for therapeutic actions and reduces psychological burden.   The architecture of BIP encompasses a ground-breaking, lifelong lasting implanted ip glucose nanosensor; a radically novel ip hormone delivery pump, with unique non-invasive hormone refill with a magnetic docking pill and non-invasive wireless battery recharge; an intelligent closed-loop hormone dosing algorithm, optimized for ip sensing and delivery, individualized, adaptive and equipped with advanced self-diagnostic algorithms.     Pump refilling through a weekly oral recyclable drug pill will free T1D subjects from the burden of pain and awkward daily measurement and treatment actions. Wireless power transfer and data transmission to cloud-based data management system round-up to a revolutionary treatment device for this incurable chronic disease. key feature of BIP is to be fully-implantable and life-long lasting thanks to novel biocompatible and immune-optimized coatings guaranteeing long-term safety and stability https://www.stocktitan.net/news/GCTK/glucotrack-to-participate-in-forgetdiabetes-a-prominent-european-cjjldjb0dq7h.html XX A newly recognised form of diabetes, called Type 5, was announced this week at the World Congress of Diabetes 2025. A global task force will investigate this less-understood condition, which differs from Type 1 and Type 2 diabetes. Type 5 diabetes affects people who are underweight, lack a family history of diabetes and do not show the typical symptoms of Type 1 or Type 2 diabetes. The condition was first observed in the 1960s and referred to as J-type diabetes, after being detected in Jamaica. It was classified by the World Health Organisation in 1985, but removed in 1998 due to lack of physiological evidence. At the time, experts believed it to be a misdiagnosed case of Type 1 or 2 diabetes. New research has since confirmed that Type 5 is different. https://economictimes.indiatimes.com/news/new-updates/a-new-type-of-diabetes-has-been-found-by-scientists-and-it-doesnt-show-the-typical-symptoms-of-type-1-or-type-2/articleshow/120276658.cms?from=mdr   XX Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. A new clinical trial, co-led by endocrinologist and diabetes specialist John Buse, MD, PhD, and interventional cardiologist Matthew Cavender, MD, MPH, at the UNC School of Medicine, has demonstrated that the oral form of semaglutide significantly lowers the risk of cardiovascular events in individuals with type 2 diabetes, atherosclerotic cardiovascular disease, and/or chronic kidney disease. Results from the rather large, international trial were published in the New England Journal of Medicine and presented at the American College of Cardiology's Annual Scientific Session & Expo in Chicago, Illinois.     The effect of oral semaglutide on cardiovascular outcomes was consistent with other clinical trials involving injectable semaglutide, but more trials are needed to determine if one method may be more effective than the other at reducing major cardiovascular events. https://scitechdaily.com/new-pill-form-of-semaglutide-shows-major-benefits-for-people-with-diabetes/ XX April 14 (UPI) -- The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to treat Type 2 diabetes, have been found in the United States. Novo Nordisk, the Danish-headquartered manufacturer, informed the FDA on April 3 that counterfeit 1-milligram injections of semaglutide were being distributed outside its authorized supply chain. The FDA and Novo Nordisk are testing the fake products to identify whether they're safe. Patients are asked to obtain Ozempic with a valid prescription through state-licensed pharmacies and check the product for any signs of counterfeiting. People in possession of the fake product are urged to call Novo Nordisk customer care at 800-727-6500 Monday through Friday from 8:30 a.m. to 6 p.m. EDT and report it to the FDA's criminal activity division's website. Side effects can be reported to FDA's MedWatch Safety Information and Adverse Event Reporting Program (800-FDA-1088 or www.fda.gov/medwatch) as well as to Novo Nordisk, at 800-727-6500. https://www.upi.com/Health_News/2025/04/14/FDA-fake-Ozempic-drugs-Novo-Nordisk/6841744666854/ XX Can a digital lifestyle modification program reduce diabetes risk? A new study shows that the lifestyle intervention significantly reduced 10-year diabetes risk among prediabetics by nearly 46% and increased the diabetes remission rate, highlighting the importance of lifestyle changes. However, the study was not a randomized trial, and participation in the lifestyle intervention was voluntary, which may introduce selection bias. The study evaluated 133,764 adults, categorizing them as diabetic (7.5%), prediabetic (36.2%), and healthy (56.3%), based on fasting glucose and HbA1c levels. https://www.news-medical.net/news/20250414/Digital-lifestyle-program-cuts-diabetes-risk-by-4625-in-prediabetics-study-of-130k2b-adults-reveals.aspx XX Chrissy Teigan is speaking out about her son's type 1 diagnosis – teaming up with Sanofi to encourage people to screen early for Type 1 diabetes.   Teigen got a crash course in the risks of undiagnosed Type 1 diabetes when her 6-year-old son, Miles, was hospitalized with complications of the autoimmune disease last year. The family knew nothing about Type 1 diabetes when Miles was diagnosed during an unexpected medical emergency, Teigen said in a Tuesday announcement. “We were confused and scared when Miles was first diagnosed,” she said in a statement. “There is no doubt in my mind that knowing in advance would have made a positive impact for Miles, me, and our entire family. I want everyone to hear me when I say: stay proactive and talk to your doctor about getting yourself or your loved ones screened for type 1 diabetes today!”   Teigen shared her family's story in a two-minute video on ScreenForType1.com, a Sanofi website that discusses how to get screened for the condition. Miles' diagnosis made Teigen feel like she “went from a mom to a doctor overnight,” she said. That experience is why Teigen said she is “begging you: Do this one thing, and screen yourself and your family for Type 1 diabetes.” https://www.fiercepharma.com/marketing/sanofi-signs-chrissy-teigen-diabetes-screening-campaign XX Dr. Richard Bernstein – best known for his advocacy around low carb diets for people with diabetes – died this week at the age of 90. Born in 1934 in Brooklyn, New York, he was diagnosed with type 1 at age 12. In the 1970s he adapted a blood glucose monitor for home use and helped pioneer home glucose monitoring. He published multiple books on Diabetes including the #1 selling Diabetes book on Amazon.Com “Dr. Bernstein's Diabetes Solution: A Complete Guide to Achieving Normal Blood Sugars” and “Diabetes Type II: Living a Long, Healthy Life Through Blood Sugar Normalization”.  He practiced and saw patients right up until his death.

Steve Bierman, MD is the Director of the Noetic Medicine Institute at the Andrew Weil Center for Integrative Medicine (University of Arizona, College of Medicine). He is also the author of two award-winning books on Noetic Medicine: HEALING (2020) and The END of WORRY (2023). Dr. Bierman is a graduate of Northwestern University's School of Medicine and was board certified in and practiced Emergency and Family Medicine. He is also a diplomate of the American Board of Medical Hypnosis. Dr. Bierman teaches noetic medicine (“mind medicine”) around the world, reminding caregivers that MIND MATTERS – that “the words of a caregiver can harm or heal.” You can connect with Dr. Bierman via YouTube @SteveBierman and the website www.healingbeyondpills.com View his recently published paper, Placebo and the law of identification, here. Related Episodes: Ep 299 - Dr. Wayne Jonas on  Whole Person Care for Cancer and Healing Ep 262 - Upgrade your Language with Mark England If you like this episode, please subscribe to Pursuing Health on iTunes and give it a rating or share your feedback on social media using the hashtag #PursuingHealth. I look forward to bringing you future episodes with inspiring individuals and ideas about health. Disclaimer: This podcast is for general information only, and does not provide medical advice.  I recommend that you seek assistance from your personal physician for any health conditions or concerns.

What if your health breakthrough doesn't start in the gym or the kitchen—but in your mind?In this powerful conversation, Michael and Megan sit down with Dr. Josh Axe to explore why so many people feel stuck in cycles of stress, illness, or plateau—and how to shift toward real, lasting wellness. Drawing from his background in functional medicine and personal experience with a life-altering spinal infection, Dr. Axe shares the most overlooked key to healing and how you can start applying it today.Memorable Quotes“The number one determining factor of longevity for you is having strong relationships.”“If you wake up first thing in the morning and get outside, it's one of the single greatest things you can do for longevity and your microbiome.”“This is all about training your nervous system and encouraging your body that ‘This is going to happen.'”“There's a lot of people that win at all costs, but they never end up winning. We hear all the stories. They're never truly winning.”Key TakeawaysThe Biology of Belief. What you believe about your body impacts everything from gut function to recovery speed. Healing starts with mindset.The Root of the Issue. Many chronic health challenges are driven by unresolved trauma—and show up in unexpected places like digestion and fatigue.The Power of Visualization. Mentally rehearsing health and healing isn't “woo-woo”—it's neuroscience.Top Four Longevity Habits. Hear from an expert what four rituals can add years to your life.ResourcesThink This, Not That by Dr. Josh AxeDrAxe.comAncient NutritionYou Are the Placebo by Dr. Joe DispenzaWatch on Youtube at:  https://youtu.be/2-dvOt-zcdMThis episode was produced by Sarah Vorhees Wendel of VW Sound